<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-037748</identifier>
<setSpec>0009-739X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prosthetic replacement of the inferior vena cava. Current controversies</dc:title>
<dc:description xml:lang="en">A ringed polytetrafluoroethylene (PTFE) graft is currently    the most widely used replacement for the inferior    vena cava, although clinical studies comparing this technique with non-ringed prostheses are lacking. There is no consensus on the need to use an anticoagulant or associate a temporary distal arteriovenous    fistula to increase venous flow. At present, the best therapeutic strategy cannot be determined. We present a case of retroperitoneal sarcoma infiltrating    the infrarenal vena cava, right colon and ureter  that was surgically treated in our hospital. En bloc resection was performed and the vena cava was reconstructed    using a non-ringed PTFE graft associated with systemic anticoagulation (AU)</dc:description>
<dc:creator>Navarro, Jorge</dc:creator>
<dc:creator>Clarós, Antonio</dc:creator>
<dc:creator>Manzanet, Gerardo</dc:creator>
<dc:creator>Suelves, Consuelo</dc:creator>
<dc:creator>Corell, Ricardo</dc:creator>
<dc:creator>Trías, Asumpta</dc:creator>
<dc:creator>Morón, Ramón</dc:creator>
<dc:creator>Castell, Lucas</dc:creator>
<dc:creator>Peiró, Eduardo</dc:creator>
<dc:creator>Calderón, Rogelio</dc:creator>
<dc:creator>Todolí, Gonzalo</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La prótesis anillada de politetrafluoroetileno (PTFE) es el sustitutivo de la vena cava inferior más empleado    en la actualidad, aunque carecemos de estudios clínicos que la comparen con prótesis no anilladas. No hay consenso respecto a la necesidad de anticoagular    o de asociar una fístula arteriovenosa distal temporal que aumente el flujo venoso. Por el momento    no podemos determinar cuál es la mejor estrategia terapéutica. Presentamos 1 caso de sarcoma retroperitoneal intervenido    en nuestro hospital que infiltraba la vena cava infrarrenal, el colon derecho y el uréter. Se practicó    una resección tumoral en bloque y se reconstruyó    la vena cava con una prótesis de PTFE no anillada asociada a anticoagulación sistémica (AU)</dc:description>
<dc:source>Cir. Esp. (Ed. impr.);77(3): 170-172, mar. 2005. ilus</dc:source>
<dc:identifier>ibc-037748</dc:identifier>
<dc:title xml:lang="es">Sustitución protésica de la vena cava inferior. Controversias actuales</dc:title>
<dc:subject>^d29321^s22032</dc:subject>
<dc:subject>^d5538^s22016</dc:subject>
<dc:subject>^d12603^s22009</dc:subject>
<dc:subject>^d15084^s22042</dc:subject>
<dc:subject>^d5538^s22009</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29321^s22009</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d29321^s22016</dc:subject>
<dc:subject>^d12603^s22053</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d15084^s22009</dc:subject>
<dc:subject>^d11916^s22074</dc:subject>
<dc:subject>^d12603^s29166</dc:subject>
<dc:subject>^d12603^s22016</dc:subject>
<dc:subject>^d8287^s22016</dc:subject>
<dc:subject>^d12888^s22016</dc:subject>
<dc:subject>^d8287^s22009</dc:subject>
<dc:subject>^d12888^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>200503</dc:date>
</metadata>
</record>
</ibecs-document>
